ARCHIVES

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

This article is from The Cancer Letter archive.

Vol. 07 No. 33 | August 14, 1981

Download PDF Visit The Full Archive

Related Articles

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Black Women More Likely To Delay Diagnosis, Treatment

July 29, 2005

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts

April 3, 1992

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

“Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer

October 10, 1975